JSCGX vs. NCLEX
JSCGX (Jacob Small Cap Growth Fund) and NCLEX (Nicholas Limited Edition Fund) are both Small Cap Growth Equities funds. Over the past 10 years, JSCGX returned 7.54%/yr vs 7.44%/yr for NCLEX. Their correlation of 0.81 suggests significant overlap in exposure. JSCGX charges 1.97%/yr vs 0.85%/yr for NCLEX.
Performance
JSCGX vs. NCLEX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JSCGX achieves a -26.09% return, which is significantly lower than NCLEX's -7.51% return. Both investments have delivered pretty close results over the past 10 years, with JSCGX having a 7.54% annualized return and NCLEX not far behind at 7.44%.
JSCGX
- 1D
- -1.10%
- 1M
- -4.12%
- YTD
- -26.09%
- 6M
- -26.69%
- 1Y
- 5.92%
- 3Y*
- 9.91%
- 5Y*
- -10.35%
- 10Y*
- 7.54%
NCLEX
- 1D
- -0.72%
- 1M
- 1.30%
- YTD
- -7.51%
- 6M
- -9.33%
- 1Y
- -12.00%
- 3Y*
- 0.15%
- 5Y*
- -1.65%
- 10Y*
- 7.44%
JSCGX vs. NCLEX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JSCGX Jacob Small Cap Growth Fund | -26.09% | 41.65% | 12.89% | 18.74% | -50.37% | -0.60% | 60.95% | 20.04% | 8.26% | 20.61% |
NCLEX Nicholas Limited Edition Fund | -7.51% | -10.41% | 11.91% | 17.17% | -23.71% | 19.07% | 22.67% | 27.36% | -0.94% | 19.93% |
Correlation
The correlation between JSCGX and NCLEX is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.71 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.74 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.79 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.78 |
Correlation (All Time) Calculated using the full available price history since Feb 1, 2010 | 0.81 |
The correlation between JSCGX and NCLEX has been stable across timeframes, ranging from 0.71 to 0.81 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JSCGX vs. NCLEX — Risk / Return Rank
JSCGX
NCLEX
JSCGX vs. NCLEX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Jacob Small Cap Growth Fund (JSCGX) and Nicholas Limited Edition Fund (NCLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JSCGX | NCLEX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.86 | ||
| Sortino ratioReturn per unit of downside risk | +1.31 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 0.91 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 0.21 | -0.49 | +0.71 |
| Martin ratioReturn relative to average drawdown | 0.43 | -0.98 | +1.42 |
Loading charts...
Drawdowns
JSCGX vs. NCLEX - Drawdown Comparison
The maximum JSCGX drawdown since its inception was -70.07%, which is greater than NCLEX's maximum drawdown of -48.68%. Use the drawdown chart below to compare losses from any high point for JSCGX and NCLEX.
Loading charts...
Drawdown Indicators
| JSCGX | NCLEX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.07% | -48.68% | -21.39% |
Max Drawdown (1Y)Largest decline over 1 year | -32.69% | -21.36% | -11.33% |
Max Drawdown (3Y)Largest decline over 3 years | -32.69% | -28.50% | -4.19% |
Max Drawdown (5Y)Largest decline over 5 years | -67.86% | -28.50% | -39.36% |
Max Drawdown (10Y)Largest decline over 10 years | -70.07% | -35.79% | -34.28% |
Current DrawdownCurrent decline from peak | -48.76% | -22.62% | -26.14% |
Average DrawdownAverage peak-to-trough decline | -25.16% | -8.30% | -16.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.98% | 10.72% | +5.26% |
Volatility
JSCGX vs. NCLEX - Volatility Comparison
Jacob Small Cap Growth Fund (JSCGX) has a higher volatility of 9.89% compared to Nicholas Limited Edition Fund (NCLEX) at 4.54%. This indicates that JSCGX's price experiences larger fluctuations and is considered to be riskier than NCLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JSCGX | NCLEX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.89% | 4.54% | +5.35% |
Volatility (6M)Calculated over the trailing 6-month period | 20.74% | 12.41% | +8.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.18% | 17.04% | +12.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.32% | 19.55% | +16.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.82% | 19.23% | +13.59% |
JSCGX vs. NCLEX - Expense Ratio Comparison
JSCGX has a 1.97% expense ratio, which is higher than NCLEX's 0.85% expense ratio.
Dividends
JSCGX vs. NCLEX - Dividend Comparison
JSCGX has not paid dividends to shareholders, while NCLEX's dividend yield for the trailing twelve months is around 8.15%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JSCGX Jacob Small Cap Growth Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 18.09% | 13.69% | 2.57% | 1.13% | 0.00% | 0.00% | 0.59% |
NCLEX Nicholas Limited Edition Fund | 8.15% | 7.53% | 2.51% | 2.43% | 6.22% | 16.44% | 5.10% | 5.66% | 10.72% | 7.97% | 10.68% | 8.05% |
Frequently Asked Questions
JSCGX and NCLEX have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JSCGX has higher volatility (9.89%) compared to NCLEX (4.54%). In terms of maximum drawdown, JSCGX dropped -70.07% vs NCLEX's -48.68%.
JSCGX currently has the higher Sharpe Ratio (0.24 vs -0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JSCGX and NCLEX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer